Abstract
We assessed interventional clinical trials for hidradenitis suppurativa from 2006 to 2021 noting patient demographics, intervention types and reported outcomes. We report and analyse the emerging trend towards biologic treatments. We also discuss that across studies, more consistent documentation of patient characteristics as well as more variable intervention types may broaden trial generalizability and provide benefit to more patients.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
